Follicular Lymphoma

This article looks at the survival rate for Follicular lymphoma

Follicular lymphoma is classified as a Non-Hodgkin's Lymphoma. It

The Food and Drug Administration has approved Gazyva plus bendamustine for the treatment

Biopharmaceutical company Immunomedics announced that the combination of epratuzumab and

FDA Approves Zevalin® Expanded Label as Part of First-Line Therapy in Treatment of Follicular

Autologous stem cell transplantation is linked to better survival outcomes in patients

Spectrum Pharmaceuticals is announcing that positive long-term clinical data for the

Celgene International presented data this weekend at the American Society of Clinical Oncology's

Determining which follicular lymphoma treatment options to go with—and when to go with them—is

Pennsylvania State Senator Mike Folmer (R-Lebanon) has announced that he has been

In a coup for Roche and a victory for follicular lymphoma patients in the United Kingdom,

Results of a systematic review and meta-analysis of randomized control trials ranging from 1947

Hoping to inch towards a consensus on the best treatment approach or a standard of care for

According to two new studies published online August 1 in the Journal of Clinical Oncology,